Search Results - "BEGUIN, Yves"

Soluble transferrin receptor for the evaluation of erythropoiesis and iron status by Beguin, Yves

“…Iron transport in the plasma is carried out by transferrin, which donates iron to cells through its interaction with a specific membrane receptor, the…”
Get full text

Clinical-scale expansion of mesenchymal stromal cells: a large banking experience by Lechanteur, Chantal, Briquet, Alexandra, Giet, Olivier, Delloye, Olivier, Baudoux, Etienne, Beguin, Yves

“…Mesenchymal stromal cells (MSC) are largely investigated in clinical trials aiming to control inappropriate immune reactions (GVHD, Crohn's disease, solid…”
Get full text

Infusion of mesenchymal stromal cells after deceased liver transplantation: A phase I–II, open-label, clinical study by Detry, Olivier, Vandermeulen, Morgan, Delbouille, Marie-Hélène, Somja, Joan, Bletard, Noella, Briquet, Alexandra, Lechanteur, Chantal, Giet, Olivier, Baudoux, Etienne, Hannon, Muriel, Baron, Frederic, Beguin, Yves

“…Graphical abstract…”
Get full text

Bispecific, T-Cell-Recruiting Antibodies in B-Cell Malignancies by Lejeune, Margaux, Köse, Murat Cem, Duray, Elodie, Einsele, Hermann, Beguin, Yves, Caers, Jo

“…Bispecific antibodies (BsAbs) are designed to recognize and bind to two different antigens or epitopes. In the last few decades, BsAbs have been developed…”
Get full text

Adherence to Sars-CoV2 vaccination in hematological patients by Narinx, Justine, Houbiers, Margaux, Seidel, Laurence, Beguin, Yves

“…Background SARS-CoV2 vaccination efficiently prevents severe COVID-19, although hematological patients, particularly under therapy, respond less well. Besides…”
Get full text

Current Status and Perspectives of Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients with Acute Myeloid Leukemia by Sophie, Servais, Yves, Beguin, Frédéric, Baron

“…As in younger patients, allogeneic stem cell transplantation (alloHSCT) offers the best chance for durable remission in older patients (≥60 years) with acute…”
Get full text

MSC Manufacturing for Academic Clinical Trials: From a Clinical-Grade to a Full GMP-Compliant Process by Lechanteur, Chantal, Briquet, Alexandra, Bettonville, Virginie, Baudoux, Etienne, Beguin, Yves

“…Following European regulation 1394/2007, mesenchymal stromal cell (MSCs) have become an advanced therapy medicinal product (ATMP) that must be produced…”
Get full text

Mesenchymal Stromal Cells in Solid Organ Transplantation by Vandermeulen, Morgan, Erpicum, Pauline, Weekers, Laurent, Briquet, Alexandra, Lechanteur, Chantal, Detry, Olivier, Beguin, Yves, Jouret, François

“…Over the past decade, the clinical application of mesenchymal stromal cells (MSCs) has generated growing enthusiasm as an innovative cell-based approach in…”
Get full text

Impact of prior JAK-inhibitor therapy with ruxolitinib on outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis: a study of the CMWP of EBMT by Kröger, Nicolaus, Sbianchi, Giulia, Sirait, Tiarlan, Wolschke, Christine, Beelen, Dietrich, Passweg, Jakob, Robin, Marie, Vrhovac, Radovan, Helbig, Grzegorz, Sockel, Katja, Conneally, Eibhlin, Rubio, Marie Thérèse, Beguin, Yves, Finke, Jürgen, Bernasconi, Paolo, Morozova, Elena, Clausen, Johannes, von dem Borne, Peter, Schaap, Nicolaas, Schroyens, Wilfried, Patriarca, Francesca, Di Renzo, Nicola, Yeğin, Zeynep Arzu, Hayden, Patrick, McLornan, Donal, Yakoub-Agha, Ibrahim

“…JAK1/2 inhibitor ruxolitinib (RUX) is approved in patients with myelofibrosis but the impact of pretreatment with RUX on outcome after allogeneic hematopoietic…”
Get full text

European Myeloma Network recommendations on tools for the diagnosis and monitoring of multiple myeloma: what to use and when by Caers, Jo, Garderet, Laurent, Kortüm, K Martin, O'Dwyer, Michael E, van de Donk, Niels W C J, Binder, Mascha, Dold, Sandra Maria, Gay, Francesca, Corre, Jill, Beguin, Yves, Ludwig, Heinz, Larocca, Alessandra, Driessen, Christoph, Dimopoulos, Meletios A, Boccadoro, Mario, Gramatzki, Martin, Zweegman, Sonja, Einsele, Hermann, Cavo, Michele, Goldschmidt, Hartmut, Sonneveld, Pieter, Delforge, Michel, Auner, Holger W, Terpos, Evangelos, Engelhardt, Monika

“…The diagnosis of multiple myeloma can be challenging, even for experienced physicians, and requires close collaboration between numerous disciplines…”
Get full text

Long-term longitudinal evaluation of the prevalence of SARS-CoV-2 antibodies in healthcare and university workers by Huynen, Pascale, Grégoire, Céline, Gofflot, Stéphanie, Seidel, Laurence, Maes, Nathalie, Vranken, Laura, Delcour, Sandra, Moutschen, Michel, Hayette, Marie-Pierre, Kolh, Philippe, Melin, Pierrette, Beguin, Yves

“…Asymptomatic and pauci-symptomatic cases contribute to underestimating the prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)…”
Get full text

Comparison of Mesenchymal Stromal Cells From Different Origins for the Treatment of Graft-vs.-Host-Disease in a Humanized Mouse Model by Grégoire, Céline, Ritacco, Caroline, Hannon, Muriel, Seidel, Laurence, Delens, Loïc, Belle, Ludovic, Dubois, Sophie, Vériter, Sophie, Lechanteur, Chantal, Briquet, Alexandra, Servais, Sophie, Ehx, Gregory, Beguin, Yves, Baron, Frédéric

“…Mesenchymal stromal cells (MSCs) have potent immunomodulatory properties that make them an attractive tool against graft- vs.-host disease (GVHD). However,…”
Get full text

Did Osteoblastic Cell Therapy Improve the Prognosis of Pre-fracture Osteonecrosis of the Femoral Head? A Randomized, Controlled Trial by Hauzeur, Jean-Philippe, Lechanteur, Chantal, Baudoux, Etienne, De Maertelaer, Viviane, Pather, Sanjiva, Katz, Raphael, Malaise, Michel, Ino, Julia, Beguin, Yves

“…In patients with nontraumatic osteonecrosis of the femoral head (ONFH), implantation of bone marrow aspirate concentrate (BMAC) could delay the progression of…”
Get full text

Bone Marrow-Derived Mesenchymal Stromal Cell Therapy in Severe COVID-19: Preliminary Results of a Phase I/II Clinical Trial by Grégoire, Céline, Layios, Nathalie, Lambermont, Bernard, Lechanteur, Chantal, Briquet, Alexandra, Bettonville, Virginie, Baudoux, Etienne, Thys, Marie, Dardenne, Nadia, Misset, Benoît, Beguin, Yves

“…Background Treatment of acute respiratory distress syndrome (ARDS) associated with COronaVIrus Disease-2019 (COVID-19) currently relies on dexamethasone and…”
Get full text

Sequential administration of low dose 5-azacytidine (AZA) and donor lymphocyte infusion (DLI) for patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) in relapse after allogeneic stem cell transplantation (SCT): a prospective study from the Belgian Hematology Society (BHS) by Poiré, Xavier, Graux, Carlos, Ory, Aurélie, Herman, Julie, Baron, Frédéric, Schoemans, Hélène, Lewalle, Philippe, De Becker, Ann, Deeren, Dries, Berneman, Zwi, Kerre, Tessa, Zachée, Pierre, Selleslag, Dominik, Beguin, Yves

Get full text

Impact of Azacitidine Before Allogeneic Stem-Cell Transplantation for Myelodysplastic Syndromes: A Study by the Société Française de Greffe de Moelle et de Thérapie-Cellulaire and the Groupe-Francophone des Myélodysplasies by DAMAJ, Gandhi, DUHAMEL, Alain, BULABOIS, Claude-Eric, HUYNH, Anne, BAY, Jacques-Olivier, LEGRAND, Faeyzeh, DECONINCK, Eric, FEGUEUX, Nathalie, CLEMENT, Laurence, DAURIAC, Charles, MAILLARD, Natacha, CORNILLON, Jérôme, ROBIN, Marie, ADES, Lionel, GUILLERM, Gaelle, SCHMIDT-TANGUY, Aline, MARJANOVIC, Zora, PARK, Sophie, RUBIO, Marie-Thérèse, MAROLLEAU, Jean-Pierre, GARNIER, Federico, FENAUX, Pierre, YAKOUB-AGHA, Ibrahim, BEGUIN, Yves, MICHALLET, Mauricette, MOHTY, Mohamad, VIGOUROUX, Stephane, BORIES, Pierre, GARNIER, Alice, EL CHEIKH, Jean

“…To investigate the impact of prior-to-transplantation azacitidine (AZA) on patient outcome after allogeneic stem-cell transplantation (alloSCT) for…”
Get full text

Chimeric Antigen Receptor-T-Cell Therapy for B-Cell Hematological Malignancies: An Update of the Pivotal Clinical Trial Data by Roex, Gils, Feys, Tom, Beguin, Yves, Kerre, Tessa, Poiré, Xavier, Lewalle, Philippe, Vandenberghe, Peter, Bron, Dominique, Anguille, Sébastien

“…Chimeric antigen receptor (CAR)-T-cell therapy is an innovative form of adoptive cell therapy that has revolutionized the treatment of certain hematological…”
Get full text

Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipients by Canti, Lorenzo, Humblet-Baron, Stéphanie, Desombere, Isabelle, Neumann, Julika, Pannus, Pieter, Heyndrickx, Leo, Henry, Aurélie, Servais, Sophie, Willems, Evelyne, Ehx, Grégory, Goriely, Stanislas, Seidel, Laurence, Michiels, Johan, Willems, Betty, Liston, Adrian, Ariën, Kevin K, Beguin, Yves, Goossens, Maria E, Marchant, Arnaud, Baron, Frédéric

“…Factors affecting response to SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic stem cell transplantation (allo-HCT) recipients remain to be elucidated…”
Get full text

High proportion of terminally differentiated regulatory T cells after allogeneic hematopoietic stem cell transplantation by Ritacco, Caroline, Ehx, Grégory, Grégoire, Céline, Daulne, Coline, Willems, Evelyne, Servais, Sophie, Beguin, Yves, Baron, Frédéric

“…It is now well-established that regulatory T cells (Treg) represent a heterogeneous group of CD4 + T cells. Previous studies have demonstrated that Treg…”
Get full text

Mesenchymal Stromal Cell Therapy in Ischemia/Reperfusion Injury by Jouret, François, Krzesinski, Jean-Marie, Briquet, Alexandra, Lechanteur, Chantal, Grégoire, Céline, Weekers, Laurent, Detry, Olivier, Erpicum, Pauline, Rowart, Pascal, Beguin, Yves

“…Ischemia/reperfusion injury (IRI) represents a worldwide public health issue of increasing incidence. IRI may virtually affect all organs and tissues and is…”
Get full text